[go: up one dir, main page]

NL8301996A - Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. - Google Patents

Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. Download PDF

Info

Publication number
NL8301996A
NL8301996A NL8301996A NL8301996A NL8301996A NL 8301996 A NL8301996 A NL 8301996A NL 8301996 A NL8301996 A NL 8301996A NL 8301996 A NL8301996 A NL 8301996A NL 8301996 A NL8301996 A NL 8301996A
Authority
NL
Netherlands
Prior art keywords
vaccine
live
vaccines
preparing
emulsion
Prior art date
Application number
NL8301996A
Other languages
English (en)
Dutch (nl)
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19841956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL8301996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to NL8301996A priority Critical patent/NL8301996A/nl
Application filed by Duphar Int Res filed Critical Duphar Int Res
Priority to FI842215A priority patent/FI79787C/fi
Priority to DK273384A priority patent/DK273384A/da
Priority to US06/616,144 priority patent/US4650677A/en
Priority to ES533111A priority patent/ES8502870A1/es
Priority to JP11398984A priority patent/JPH0639386B2/ja
Priority to EP19840200796 priority patent/EP0129923B1/en
Priority to IE1388/84A priority patent/IE57927B1/en
Priority to DE8484200796T priority patent/DE3473825D1/de
Priority to AT84200796T priority patent/ATE36956T1/de
Publication of NL8301996A publication Critical patent/NL8301996A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Stereophonic System (AREA)
NL8301996A 1983-06-06 1983-06-06 Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. NL8301996A (nl)

Priority Applications (10)

Application Number Priority Date Filing Date Title
NL8301996A NL8301996A (nl) 1983-06-06 1983-06-06 Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
FI842215A FI79787C (fi) 1983-06-06 1984-06-01 Foerfarande foer framstaellning av ett levande virusvaccin.
DK273384A DK273384A (da) 1983-06-06 1984-06-01 Levende adjuvansholdige vacciner og fremgangsmaader til fremstilling af saadanne vacciner
US06/616,144 US4650677A (en) 1983-06-06 1984-06-01 Method of preparing adjuvanted live attenuated vaccines and adjuvanted live attenuated vaccines thus obtained
ES533111A ES8502870A1 (es) 1983-06-06 1984-06-04 Un metodo de preparar una vacuna viva
JP11398984A JPH0639386B2 (ja) 1983-06-06 1984-06-05 アジュバント生ワクチンの製造方法
AT84200796T ATE36956T1 (de) 1983-06-06 1984-06-05 Verfahren zu herstellung von lebenden, adjuvierten impfstoffen und so erhaltende lebende, adjuvierte impfstoffe.
EP19840200796 EP0129923B1 (en) 1983-06-06 1984-06-05 Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
IE1388/84A IE57927B1 (en) 1983-06-06 1984-06-05 Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
DE8484200796T DE3473825D1 (en) 1983-06-06 1984-06-05 Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8301996 1983-06-06
NL8301996A NL8301996A (nl) 1983-06-06 1983-06-06 Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.

Publications (1)

Publication Number Publication Date
NL8301996A true NL8301996A (nl) 1985-01-02

Family

ID=19841956

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301996A NL8301996A (nl) 1983-06-06 1983-06-06 Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.

Country Status (10)

Country Link
US (1) US4650677A (es)
EP (1) EP0129923B1 (es)
JP (1) JPH0639386B2 (es)
AT (1) ATE36956T1 (es)
DE (1) DE3473825D1 (es)
DK (1) DK273384A (es)
ES (1) ES8502870A1 (es)
FI (1) FI79787C (es)
IE (1) IE57927B1 (es)
NL (1) NL8301996A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
EP0382271B1 (en) * 1989-02-04 1994-12-21 Akzo Nobel N.V. Tocols as adjuvant in vaccine
DE4040246A1 (de) * 1990-02-20 1991-08-22 Avt Anlagen Verfahrenstech Wanderbettreaktor, insbesondere zur behandlung von rauchgasen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
WO1993024147A1 (en) * 1992-05-29 1993-12-09 Smithkline Beecham Corporation Lecithin adjuvanted modified live virus vaccines
US5738854A (en) * 1992-10-06 1998-04-14 Akzo Nobel N.V. Pseudorabies virus vaccine
ES2053402B1 (es) * 1993-01-15 1995-02-01 Hipra Lab Sa Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
NZ285324A (en) * 1994-05-10 1998-08-26 American Home Prod Vaccine containing modified live bovine respiratory syncytial virus (brsv) with an adjuvant and pharmaceutically acceptable carrier
RU2123331C1 (ru) * 1996-03-28 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ получения живой коревой вакцины
RU2140288C1 (ru) * 1998-04-09 1999-10-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ получения живой коревой вакцины
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
CA2765511C (en) * 2009-06-16 2015-05-12 The Regents Of The University Of Michigan Nanoemulsion vaccines
FR2957803B1 (fr) * 2010-03-24 2012-06-01 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Diluants adjuvants de vaccins vivants pour maladies porcines
FR2957933B1 (fr) * 2010-03-24 2012-04-27 Seppic Sa Vaccin vivant pour maladies aviaires
DK3116541T3 (da) 2014-03-12 2020-02-24 Bavarian Nordic As Anvendelse af olie-og-vand-emulsioner til forøgelse af b-celleresponser med modificerede vaccinia-ankara-virus
US9457540B2 (en) 2014-07-29 2016-10-04 The Boeing Company Panel-insert assembly and method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB888180A (es) * 1900-01-01
GB425406A (en) * 1933-06-07 1935-03-07 Vincent Gregory Walsh Improvements in or relating to the manufacture of medical preparations of bacterial toxins
US3083142A (en) * 1958-02-27 1963-03-26 Glaxo Group Ltd Improved swine erysipelas vaccine
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
GB1015251A (en) * 1963-03-12 1965-12-31 Glaxo Lab Ltd Aqueous pharmaceutical compositions in capsule form
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
US3492399A (en) * 1965-09-27 1970-01-27 Samuel J Prigal Emulsion compositions and methods
US3378443A (en) * 1966-04-05 1968-04-16 American Cyanamid Co Anhydrous liquid suspensions of biologics
US3435112A (en) * 1966-06-21 1969-03-25 Norden Lab Inc Repository vaccine and method of preparing the same
GB1163470A (en) * 1967-11-13 1969-09-04 Cecil Arthur Clark Improvements in or relating to Adjuvant Vaccines
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
ZA695759B (en) * 1968-09-19 1971-03-31 Merck & Co Inc Stimulation of antibody response
LU57465A1 (es) * 1968-12-04 1970-06-04
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
FR2313078A1 (fr) * 1975-02-07 1976-12-31 Anvar Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
NL7801060A (nl) * 1977-02-09 1978-08-11 Merck & Co Inc Werkwijze voor het bereiden van een afgezwakt syncytiaal ademhalingsvirus, alsmede prepara- ten en vaccins die dit virus bevatten.
US4160024A (en) 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
NL8102786A (nl) * 1981-06-10 1983-01-03 Duphar Int Res Werkwijze voor het immuniseren van varkens tegen de ziekte van aujeszky.
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.

Also Published As

Publication number Publication date
US4650677A (en) 1987-03-17
FI79787B (fi) 1989-11-30
IE841388L (en) 1984-12-06
DE3473825D1 (en) 1988-10-13
JPS6011429A (ja) 1985-01-21
FI79787C (fi) 1990-03-12
ES533111A0 (es) 1985-02-01
FI842215A0 (fi) 1984-06-01
EP0129923B1 (en) 1988-09-07
IE57927B1 (en) 1993-05-19
ES8502870A1 (es) 1985-02-01
FI842215L (fi) 1984-12-07
DK273384A (da) 1984-12-07
EP0129923A1 (en) 1985-01-02
ATE36956T1 (de) 1988-09-15
JPH0639386B2 (ja) 1994-05-25
DK273384D0 (da) 1984-06-01

Similar Documents

Publication Publication Date Title
NL8301996A (nl) Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
JP5167469B2 (ja) ワクチンにおいて使用するためのアジュバント
JP3814290B2 (ja) 抗原用のアジュバントおよびその製法ならびに用途
HU202119B (en) Adjuvant mixture and process for producing vaccine comprising same
EP1427349A2 (en) Interleukin-12 as a veterinary vaccine adjuvant
JP4108796B2 (ja) 改良型不活化ワクチン
US4291019A (en) Vaccine for infectious bovine rhinotracheitis
IE910757A1 (en) The use of zinc calcium hydroxide, lecithin and PAO as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
DE69711673T2 (de) Adjuvans, insbesondere in form einer dreiwertigen metallkation-emulsion sowie diese enthaltende impfstoffzusammensetzung
JP2000219637A (ja) エリシペロスリクス・ルシオパシエ抗原及びワクチン組成物
JPH0687759A (ja) 新規な併用ワクチン
US20060222660A1 (en) Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference
GB2052983A (en) Vaccine for infectious bovine rhinotracheitis
JP2003520249A (ja) イヌヘルペスウイルス病に対するワクチン接種法とワクチン
MXPA97007402A (es) Vacunas inactivadas mejoradas
AU2002335754A1 (en) Interleukin-12 as a veterinary vaccine adjuvant

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed